Outer Biosciences
PrivateLast Round
Early Funding
Aug 22, 2026
Total Funding Raised
$23M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Outer Biosciences operates in Healthcare & Life Sciences and is based in Malden, Massachusetts. Its latest recorded funding round was an Early Funding round in August 2026.
Outer Biosciences is a biotechnology company that utilizes artificial intelligence and living human skin tissue models to discover and develop novel bioactive compounds for skincare and pharmaceutical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Outer Biosciences Comparables
Compare Outer Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ten Bio Ltd | 87% | |
| Stratum Biosciences | 84% | |
| Genoskin | 82% |
For institutional investors. Book with your work email.
Outer Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 22, 2026 | ||||
| Seed | Mar 14, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Outer Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Angel | Early Funding |
| Calm Capital | Seed |
| Hawktail Management | Early Funding, Seed |
| Wing Venture Capital | Early Funding |
| Initialized Capital Management | Early Funding |
| Sozo Ventures | Early Funding |
| Third Kind Venture Capital | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased 7x to 7 positions, 25% of headcount.
- Oct 3, 2026
Grew 27% QoQ, from 22 to 28 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 26, 2026
In Aug '26, Outer Bio receives $23M in a later-stage venture round led by Wing Venture Capital, with participation from Initialized Capital and Hawktail, to provide human-based biological data for biotech and consumer-health companies.
- hiresAug 24, 2026
Outer Bio co-founder Lady Gaga publicly announces her role at the AI and biology startup in Aug '26, alongside fiancé Michael Polansky, who has run the company since 2022.
For institutional investors. Book with your work email.
Outer Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Outer Biosciences's valuation, stock price, and market status.
Is Outer Biosciences a public or private company?
Outer Biosciences is a private company.
What is the current stock price of Outer Biosciences?
Outer Biosciences is a private company, so its shares have no public market price. Caplight tracks Outer Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Outer Biosciences worth (valuation)?
Valuation information for Outer Biosciences is not publicly available.
Can I buy Outer Biosciences stock?
Outer Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Outer Biosciences's last funding round?
Outer Biosciences's most recent funding round was Early Funding on August 22, 2026.
Who are the main investors in Outer Biosciences?
Key investors in Outer Biosciences include Wing Venture Capital.
Will Outer Biosciences IPO soon?
No public IPO plans have been announced for Outer Biosciences.
How can I track Outer Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Outer Biosciences's shares on secondary markets.